Condition: Focal Onset Seizure · Primary Generalized Epilepsy · Sponsor: Praxis Precision Medicines
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures
This description comes directly from the study's public registry record.
Head of Pharmacovigilance · 617-300-8460 · clinicaltrials@praxismedicines.com
Always discuss trial participation with your own doctor first.
| Praxis Research Site | Phoenix, Arizona, United States | Recruiting |
| Praxis Research Site | Miami Lakes, Florida, United States | Recruiting |
| Praxis Research Site | Bethesda, Maryland, United States | Recruiting |
| Praxis Research Site | Chesterfield, Missouri, United States | Recruiting |
| Praxis Research Site | Hackensack, New Jersey, United States | Recruiting |
| Praxis Research Site | Middletown, New York, United States | Recruiting |
| Praxis Research Site | Round Rock, Texas, United States | Recruiting |
| Praxis Research Site | Seabrook, Texas, United States | Recruiting |
| Praxis Research Site | Heidelberg, Australia | Recruiting |
| Praxis Research Site | Melbourne, Australia | Recruiting |
| Praxis Research Site | Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06908356